Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005086 |
---|---|
Receipt number | R000006047 |
Scientific Title | Phase II trial of induction gefitinib followed by cisplatin and docetaxel with concurrent radiotherapy in locally advanced non-small cell lung cancer with EGFR activating mutation |
Date of disclosure of the study information | 2011/02/15 |
Last modified on | 2022/04/08 15:26:50 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/02/15 10:42:59 | ||
2 | Update | 2011/08/16 09:32:12 | Organization Organization Division name Division name Address Address TEL Organization Organization Division name Division name Address Address TEL Institute Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Institutions |
|
3 | Update | 2012/09/24 14:01:51 | Division name Division name Institutions |
|
4 | Update | 2012/09/24 14:08:34 | Institutions |
|
5 | Update | 2013/02/15 16:21:39 | Institutions |
|
6 | Update | 2013/08/15 17:40:36 | Division name Division name Name of person sending information Name of person sending information Organization Organization Division name Division name Address Address TEL |
|
7 | Update | 2014/02/17 10:17:32 | Email Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address TEL Address Institutions |
|
8 | Update | 2014/02/17 10:19:46 | Last follow-up date |
|
9 | Update | 2014/10/01 16:16:46 | Key inclusion criteria Key inclusion criteria Target sample size |
|
10 | Update | 2014/10/01 16:20:05 | Institutions |
|
11 | Update | 2015/02/25 11:23:34 | Institutions |
|
12 | Update | 2015/08/24 14:27:14 | Institutions |
|
13 | Update | 2016/07/26 13:31:04 | Name of primary person or sponsor Organization |
|
14 | Update | 2018/03/20 09:31:50 | Recruitment status |
|
15 | Update | 2022/04/08 15:21:14 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name Zip code Address Address TEL Last name of contact person Last name of contact person Organization Zip code Address Organization1 Address1 Tel1 Email1 Organization Organization Address Address Tel Institutions |
|
16 | Update | 2022/04/08 15:26:50 | Recruitment status Date of IRB Last follow-up date |